Clover Health Investments, Corp vs Pfizer, Inc. — Stock Comparison

CLOV
Clover Health Investments, Corp
$2.71
▼ 1.45%
vs
PFE
Pfizer, Inc.
$26.33
▼ 1.39%
Q·Score Winner
Pfizer, Inc.
PFE6.5/10vs 5.3/10

Q·Score Breakdown

5.3
Bearish
Overall
6.5
Neutral
1.5
Quality
7.4
8
Health
7
7.3
Growth
5.6
6.3
Valuation
6.7
4.1
Sentiment
5.2
CLOV

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-4% margin).

PFE

Strong profitability with 12% net profit margins.

analyst sentiment is cautious.

Analyst Consensus

HOLD
Target $2.82 (+3.9%)
3 analysts
HOLD
Target $29.00 (+10.2%)
27 analysts

Fundamentals

CLOV
PFE
Trailing P/E
19.4×
30.1×
Forward P/E
9.4×
-4.4%
Profit Margin
12.4%
18.5%
Gross Margin
75.8%
-26.3%
ROE
8.9%
44.7%
Revenue Growth
-1.2%
Earnings Growth
2.25
Beta
0.39
Price / Book
$1.4B
Market Cap
$149.8B
$2 – $4
52-Week Range
$22 – $29

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →